GF
TMCI icon

Gabelli Funds’s Treace Medical Concepts TMCI Stock Holding History

Gabelli Funds’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-88,500
Closed -$594K – 1297
2025
Q3 		$594K Sell
88,500
-2,188
-2% -$14.3K ﹤0.01% 1019
2025
Q2 		$533K Sell
90,688
-1,812
-2% -$11.8K ﹤0.01% 1008
2025
Q1 		$776K Hold
92,500
– – 0.01% 832
2024
Q4 		$688K Sell
92,500
-35,000
-27% -$234K 0.01% 856
2024
Q3 		$740K Hold
127,500
– – 0.01% 838
2024
Q2 		$848K Sell
127,500
-15,859
-11% -$128K 0.01% 814
2024
Q1 		$1.87M Hold
143,359
– – 0.01% 673
2023
Q4 		$1.83M Buy
143,359
+2,107
+1% +$21.3K 0.01% 679
2023
Q3 		$1.85M Buy
141,252
+64,959
+85% +$1.19M 0.02% 668
2023
Q2 		$1.95M Hold
76,293
– – 0.01% 659
2023
Q1 		$1.92M Buy
+76,293
New +$1.79M 0.01% 661

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Gabelli Funds's TMCI Position: Q4 2025 in Review

Gabelli Funds sold out of Treace Medical Concepts (TMCI) in Q4 2025, closing a stake of 88,500 shares — an estimated $594K sold.

Gabelli Funds first reported a position in TMCI in Q1 2023 and held it in 11 quarters. The position peaked at $1.95M in Q2 2023. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • Gabelli Funds reported no remaining Treace Medical Concepts position as of Q4 2025 after selling out during the quarter.
  • Gabelli Funds sold 88,500 Treace Medical Concepts shares in Q4 2025, an estimated $594K.
  • Gabelli Funds first reported a position in Treace Medical Concepts in Q1 2023 and held it in 11 quarters.
  • Gabelli Funds's Treace Medical Concepts position peaked at $1.95M in Q2 2023.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Gabelli Funds's 13F filing for Q4 2025, filed 5 Feb 2026.